Mometasone Furoate Market Players:
- Perrigo Company plc
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bausch Health Companies Inc.
- Glenmark Pharmaceuticals Limited
- Vetoquinol USA
- AstraZeneca plc
- Intersect ENT
- Hikma Pharmaceuticals
- Medlab Pharmaceuticals Private Limited
- AdvaCare Pharma
- Dermocare Laboratories
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of mometasone furoate is evaluated at USD 1.2 billion.
The global mometasone furoate market size exceeded USD 1.13 billion in 2025 and is set to expand at a CAGR of over 6.6%, surpassing USD 2.14 billion revenue by 2035.
North America in the mometasone furoate market is expected to hold a 47% share by 2035, credited to the surge in awareness campaigns regarding psoriasis and the high prevalence of skin conditions like eczema.
Key players in the market include Sasol Limited, Exxon Mobil Corporation, Croda International Plc, Procter & Gamble Co., Royal Dutch Shell plc, Clariant AG, Chevron Phillips Chemical Company LLC, BASF SE, SABIC, Emery Oleochemicals Group.
